vs
Side-by-side financial comparison of SCYNEXIS INC (SCYX) and Stabilis Solutions, Inc. (SLNG). Click either name above to swap in a different company.
SCYNEXIS INC is the larger business by last-quarter revenue ($18.6M vs $13.3M, roughly 1.4× Stabilis Solutions, Inc.). SCYNEXIS INC runs the higher net margin — 65.7% vs -2.0%, a 67.7% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs -23.3%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs -18.1%).
SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.
Stabilis Solutions, Inc.SLNGEarnings & Financial Report
Stabilis Solutions, Inc. is a leading North American small-scale liquefied natural gas (LNG) producer and distributor. It supplies LNG fuel, cryogenic services, and full-cycle energy solutions to industrial, remote power, transportation, and commercial clients across the United States and Canada, advancing low-emission energy transition efforts.
SCYX vs SLNG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $13.3M |
| Net Profit | $12.3M | $-262.0K |
| Gross Margin | — | 24.7% |
| Operating Margin | 56.3% | -2.4% |
| Net Margin | 65.7% | -2.0% |
| Revenue YoY | 1808.5% | -23.3% |
| Net Profit YoY | 376.5% | -112.4% |
| EPS (diluted) | $0.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $13.3M | ||
| Q3 25 | $334.0K | $20.3M | ||
| Q2 25 | $1.4M | $17.3M | ||
| Q1 25 | $257.0K | $17.3M | ||
| Q4 24 | $977.0K | $17.3M | ||
| Q3 24 | $660.0K | $17.6M | ||
| Q2 24 | $736.0K | $18.6M | ||
| Q1 24 | $1.4M | $19.8M |
| Q4 25 | $12.3M | $-262.0K | ||
| Q3 25 | $-8.6M | $1.1M | ||
| Q2 25 | $-6.9M | $-613.0K | ||
| Q1 25 | $-5.4M | $-1.6M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-2.8M | $997.0K | ||
| Q2 24 | $-14.5M | $27.0K | ||
| Q1 24 | $411.0K | $1.5M |
| Q4 25 | — | 24.7% | ||
| Q3 25 | — | 27.6% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 28.5% | ||
| Q3 24 | — | 28.3% | ||
| Q2 24 | — | 27.1% | ||
| Q1 24 | — | 31.6% |
| Q4 25 | 56.3% | -2.4% | ||
| Q3 25 | -2516.5% | 5.5% | ||
| Q2 25 | -701.0% | -2.4% | ||
| Q1 25 | -3350.2% | -9.7% | ||
| Q4 24 | — | 12.8% | ||
| Q3 24 | -1563.6% | 5.0% | ||
| Q2 24 | -1255.0% | 2.4% | ||
| Q1 24 | -692.5% | 7.8% |
| Q4 25 | 65.7% | -2.0% | ||
| Q3 25 | -2572.2% | 5.5% | ||
| Q2 25 | -504.8% | -3.5% | ||
| Q1 25 | -2097.7% | -9.2% | ||
| Q4 24 | — | 12.2% | ||
| Q3 24 | -425.5% | 5.7% | ||
| Q2 24 | -1964.4% | 0.1% | ||
| Q1 24 | 29.9% | 7.4% |
| Q4 25 | $0.25 | — | ||
| Q3 25 | $-0.17 | $0.06 | ||
| Q2 25 | $-0.14 | $-0.03 | ||
| Q1 25 | $-0.11 | $-0.09 | ||
| Q4 24 | — | $0.12 | ||
| Q3 24 | $-0.06 | $0.05 | ||
| Q2 24 | $-0.30 | $0.00 | ||
| Q1 24 | $0.01 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.0M | $7.5M |
| Total DebtLower is stronger | — | $7.9M |
| Stockholders' EquityBook value | $49.4M | $66.7M |
| Total Assets | $59.0M | $83.1M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.0M | $7.5M | ||
| Q3 25 | $37.9M | $10.3M | ||
| Q2 25 | $44.8M | $12.2M | ||
| Q1 25 | $40.6M | $9.0M | ||
| Q4 24 | $59.3M | $9.0M | ||
| Q3 24 | $68.8M | $12.4M | ||
| Q2 24 | $73.0M | $11.5M | ||
| Q1 24 | $80.2M | $8.3M |
| Q4 25 | — | $7.9M | ||
| Q3 25 | — | $8.3M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $8.9M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | — | $8.6M | ||
| Q1 24 | — | $9.1M |
| Q4 25 | $49.4M | $66.7M | ||
| Q3 25 | $36.4M | $66.7M | ||
| Q2 25 | $44.5M | $65.5M | ||
| Q1 25 | $50.5M | $65.9M | ||
| Q4 24 | $55.1M | $67.0M | ||
| Q3 24 | $58.5M | $65.4M | ||
| Q2 24 | $60.4M | $63.7M | ||
| Q1 24 | $74.1M | $63.2M |
| Q4 25 | $59.0M | $83.1M | ||
| Q3 25 | $51.1M | $87.1M | ||
| Q2 25 | $60.7M | $83.2M | ||
| Q1 25 | $67.9M | $83.1M | ||
| Q4 24 | $90.6M | $85.6M | ||
| Q3 24 | $99.0M | $89.3M | ||
| Q2 24 | $107.8M | $82.6M | ||
| Q1 24 | $118.3M | $80.6M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.13× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.4M | $669.0K |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -18.6% |
| Capex IntensityCapex / Revenue | — | 23.7% |
| Cash ConversionOCF / Net Profit | 1.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $462.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.4M | $669.0K | ||
| Q3 25 | $-8.7M | $2.4M | ||
| Q2 25 | $-7.5M | $4.5M | ||
| Q1 25 | $-7.5M | $1.0M | ||
| Q4 24 | $-24.0M | $2.2M | ||
| Q3 24 | $765.0K | $2.6M | ||
| Q2 24 | $-10.9M | $5.0M | ||
| Q1 24 | $-4.0M | $3.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $538.0K | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $3.7M | ||
| Q1 24 | — | $3.1M |
| Q4 25 | — | -18.6% | ||
| Q3 25 | — | -7.3% | ||
| Q2 25 | — | 22.4% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | -19.7% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 15.5% |
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 19.1% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 32.3% | ||
| Q3 24 | — | 7.4% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | 1.50× | — | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.03× | ||
| Q3 24 | — | 2.56× | ||
| Q2 24 | — | 186.59× | ||
| Q1 24 | -9.75× | 2.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCYX
| Glaxosmithkline Intellectual Property | $17.2M | 92% |
| Products | $1.4M | 8% |
SLNG
| Natural Gas Gathering Transportation Marketing And Processing | $11.1M | 84% |
| Other | $1.3M | 10% |
| Services | $897.0K | 7% |
